Search Results - "Illescas, D.G."
-
1
-
2
741MO Luveltamab tazevibulin (STRO-002), an anti-folate receptor alpha (FolRα) antibody drug conjugate (ADC), demonstrates clinical activity in recurrent/progressive epithelial endometrial cancer (EEC): STRO-002-GM1 phase I dose expansion
Published in Annals of oncology (01-10-2023)Get full text
Journal Article -
3
-
4
-
5
438P Real-world data of relapse after adjuvant treatment (Tx) in high-risk melanoma
Published in Annals of oncology (01-11-2020)Get full text
Journal Article -
6
318O Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients
Published in Annals of oncology (01-11-2020)Get full text
Journal Article